A total of 1623 patients with BCR-ABL1 analysis to diagnose CML, and at least 6 consecutive years of varying blood cell counts before the BCR-ABL1 test, were retrospectively included either in the train/validation or test group. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.